Clarity Pharmaceuticals Management
Management criteria checks 3/4
Clarity Pharmaceuticals' CEO is Colin Biggin, appointed in Oct 2019, has a tenure of 4.67 years. total yearly compensation is A$929.70K, comprised of 47.8% salary and 52.2% bonuses, including company stock and options. directly owns 0.58% of the company’s shares, worth $6.07M. The average tenure of the management team and the board of directors is 3.4 years and 4.5 years respectively.
Key information
Colin Biggin
Chief executive officer
AU$929.7k
Total compensation
| CEO salary percentage | 47.8% |
| CEO tenure | 4.7yrs |
| CEO ownership | 0.6% |
| Management average tenure | 3.4yrs |
| Board average tenure | 4.5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -AU$31m |
| Sep 30 2023 | n/a | n/a | -AU$28m |
| Jun 30 2023 | AU$930k | AU$444k | -AU$25m |
| Mar 31 2023 | n/a | n/a | -AU$23m |
| Dec 31 2022 | n/a | n/a | -AU$21m |
| Sep 30 2022 | n/a | n/a | -AU$23m |
| Jun 30 2022 | AU$811k | AU$347k | -AU$24m |
| Mar 31 2022 | n/a | n/a | -AU$21m |
| Dec 31 2021 | n/a | n/a | -AU$19m |
| Sep 30 2021 | n/a | n/a | -AU$15m |
| Jun 30 2021 | AU$907k | AU$308k | -AU$10m |
| Mar 31 2021 | n/a | n/a | -AU$9m |
| Dec 31 2020 | n/a | n/a | -AU$9m |
| Sep 30 2020 | n/a | n/a | -AU$8m |
| Jun 30 2020 | AU$657k | AU$303k | -AU$7m |
Compensation vs Market: Colin's total compensation ($USD617.95K) is below average for companies of similar size in the US market ($USD3.44M).
Compensation vs Earnings: Colin's compensation has increased whilst the company is unprofitable.
CEO
Colin Biggin
4.7yrs
Tenure
AU$929,701
Compensation
Dr. Colin David Biggin, Ph D., has been Managing Director, Chief Executive Officer and Executive Director at Clarity Pharmaceuticals Ltd since October 1, 2019. Dr. Biggin joined Clarity Pharmaceuticals Pty...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 10.6yrs | AU$1.13m | 4.51% A$ 47.4m | |
| MD, CEO & Executive Director | 4.7yrs | AU$929.70k | 0.58% A$ 6.1m | |
| Chief Financial Officer | 2.2yrs | AU$265.49k | no data | |
| Executive Vice President of Operations | no data | no data | no data | |
| CTO & Director of Technology | no data | AU$241.43k | 1.95% A$ 20.4m | |
| Chief Scientific Officer | 1.8yrs | no data | no data | |
| Executive Vice President of Global Clinical Operations | no data | no data | no data | |
| Company Secretary | no data | AU$268.69k | no data |
3.4yrs
Average Tenure
Experienced Management: CLRP.F's management team is considered experienced (3.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 10.6yrs | AU$1.13m | 4.51% A$ 47.4m | |
| MD, CEO & Executive Director | 4.7yrs | AU$929.70k | 0.58% A$ 6.1m | |
| Non-Executive Director | 8.3yrs | AU$81.75k | 5.75% A$ 60.4m | |
| Non-Executive Director | 5.3yrs | AU$81.75k | 0.17% A$ 1.8m | |
| Lead Independent Director | 2.8yrs | AU$79.56k | 0.38% A$ 4.0m | |
| Member of Scientific Advisory Board | 2.1yrs | no data | no data | |
| Independent Non-Executive Director | 13.7yrs | AU$90.59k | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | 4.3yrs | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | 2.2yrs | no data | no data | |
| Member of Scientific Advisory Board | 2yrs | no data | no data |
4.5yrs
Average Tenure
70yo
Average Age
Experienced Board: CLRP.F's board of directors are considered experienced (4.5 years average tenure).